Showing results (11-20 of 55) with videos related to
Sort By:
Pageof 6
Cancers|December 11, 2022
Ashkenazi Jewish and Other White APC I1307K Carriers Are at Higher Risk for Multiple CancersEsther Forkosh, Michael Bergel, Kathryn E Hatchell, et al.American Journal of Medical Genetics. Part A|January 5, 2011
Genotype-phenotype correlations of pheochromocytoma in two large von Hippel-Lindau (VHL) type 2A kindreds with different missense mutationsSarah M Nielsen, Wendy S Rubinstein, Darcy L Thull, et al.JCO Precision Oncology|September 29, 2021
Underdiagnosis of Hereditary Colorectal Cancers Among Medicare Patients: Genetic Testing Criteria for Lynch Syndrome Miss the MarkCharles Muller, Sarah M Nielsen, Kathryn E Hatchell, et al.Journal of Medical Genetics|December 14, 2024
Validation of the NCCN/Yale criteria for the identification of CDH1 pathogenic variant carriersBenjamin A Lerner, Mar Giner-Calabuig, Cassidy Carraway, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 25, 2016
The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysisSarah M Nielsen, Michael G White, Susan Hong, et al.Preventive Medicine|May 8, 2023
Racial disparities in cascade testing for cancer predisposition genesNawal M Kassem, Sandra K Althouse, Patrick O Monahan, et al.Familial Cancer|February 16, 2018
Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate riskAllison H West, Kathleen R Blazer, Jessica Stoll, et al.JAMA Network Open|October 7, 2020
Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With CancerStephen E Lincoln, Robert L Nussbaum, Allison W Kurian, et al.Annals of Surgical Oncology|October 9, 2023
Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-MakingCharles Shelton, Antonio Ruiz, Lauren Shelton, et al.Endocrine-Related Cancer|December 25, 2015
Germline PARP4 mutations in patients with primary thyroid and breast cancersYuji Ikeda, Kazuma Kiyotani, Poh Yin Yew, et al.Pageof 6